BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 24134145)

  • 21. A fatal case of erythema necroticans.
    Davis SV; Shenoi SD; Balachandran C; Pai SB
    Indian J Lepr; 2002; 74(2):145-9. PubMed ID: 12708733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythema nodosum leprosum associated with minocycline.
    Travassos AR; Antunes J; Pacheco D; Almeida LS; Filipe P; Marques MS
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):39-41. PubMed ID: 23000940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical presentations of erythema nodosum leprosum: Diagnostic and therapeutic aspects.
    Alakad R; Nofal A; Assaf M
    J Dtsch Dermatol Ges; 2021 Aug; 19(8):1133-1143. PubMed ID: 34033221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I; Dogra S; De D; Saikia UN
    Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
    Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
    Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dissimulate presentation of histoid Hansen's disease in the form of erythema nodosum leprosum.
    Pathania V; Oberoi B; Baveja S; Shelly D; Venugopal R; Shankar P
    Int J Mycobacteriol; 2019; 8(2):208-210. PubMed ID: 31210170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous ulceration as a presenting feature of type 1 lepra reaction: A case report.
    Hegde P; Jaiswal D; Shetty VM; Pai K; Rao R
    Trop Doct; 2022 Apr; 52(2):354-356. PubMed ID: 35006027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.
    Haslett PA; Roche P; Butlin CR; Macdonald M; Shrestha N; Manandhar R; Lemaster J; Hawksworth R; Shah M; Lubinsky AS; Albert M; Worley J; Kaplan G
    J Infect Dis; 2005 Dec; 192(12):2045-53. PubMed ID: 16288366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
    Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I
    Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual Presentation of Necrotic Erythema Nodosum Leprosum on Scalp: A Case Report.
    Barman KD; Madan A; Garg VK; Goel K; Khurana N
    Indian J Lepr; 2015; 87(1):23-6. PubMed ID: 26591847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
    Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective study of the severe and uncommon variants of erythema nodosum leprosum at a tertiary health center in central India.
    Wankhade VH; Debnath P; Singh RP; Sawatkar G; Bhat DM
    Int J Mycobacteriol; 2019; 8(1):29-34. PubMed ID: 30860176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B; Pallapati MS; Tarwater P; Srikantam A
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pentoxifylline in the treatment of erythema nodosum leprosum.
    De Carsalade GY; Achirafi A; Flageul B
    J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canadian case report of erythema nodosum leprosum successfully treated with prednisone and thalidomide.
    Saber M; Bourassa-Fulop C; Bouffard D; Provost N
    J Cutan Med Surg; 2010; 14(2):95-9. PubMed ID: 20338126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.